Calixarene Macrocyclic Compound Immunoassay Sensitivity Hemoglobin Interference
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current immunoassay methods face challenges in enhancing measurement sensitivity and avoiding the influence of hemoglobin, which affects the accuracy of assays, particularly in plasma-derived samples, as existing additives either fail to provide stable sensitivity enhancement or decrease measurement precision.
Innovation Solution
The use of a macrocyclic compound, such as calixarene, at a low final concentration of 0.005 to 4 mM in the reaction system enhances measurement sensitivity and prevents hemoglobin interference, allowing for accurate detection of low-concentration target substances without lot-to-lot variation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If polyethylene glycol or dextran is added to enhance measurement sensitivity, then measurement sensitivity is improved, but stable sensitivity-enhancing effect cannot be attained due to molecular weight distribution
Solution Approach 1:
The patent changes the chemical parameter from polymers with molecular weight distribution (polyethylene glycol, dextran) to a single compound with defined molecular weight (calixarene). This parameter change eliminates the instability caused by polydisperse molecular weights while maintaining the sensitivity-enhancing effect through the specific cavity structure of calixarene molecules.
2Object-affected harmful factors
If a surfactant is added to avoid hemoglobin influence, then hemoglobin interference is reduced, but measurement sensitivity decreases
Solution Approach 1:
The patent introduces calixarene as an intermediary substance that selectively binds to hemoglobin through its cavity structure, preventing hemoglobin from interfering with the antigen-antibody reaction. This intermediary approach avoids the use of surfactants that would non-specifically reduce measurement sensitivity while still eliminating hemoglobin interference.
3Measurement precision
If conventional additives are used to improve measurement sensitivity, then sensitivity enhancement is achieved, but lot-to-lot variation occurs reducing assay precision
Solution Approach 1:
The patent changes from using polymeric additives with inherent molecular weight distributions to a single compound (calixarene) with a precise molecular weight of 720. This parameter change eliminates lot-to-lot variation, as each calixarene molecule has identical binding properties, ensuring consistent assay performance across different batches.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively increases measurement sensitivity and prevents hemoglobin interference, enabling accurate assays even in samples with low target substance concentrations, while maintaining stable precision across different batches.
Implementation Method 1
non-specific reaction with various miscellaneous substances contained in a sample other than the target antigen-antibody reaction causes aggregation or absorption
Implementation Method 2
Particularly when a plasma-derived biological sample containing hemoglobin originating from hematocytes is assayed, hemoglobin may influence obtaining accurate measurements of immunoassay
Data Source
AI summary
To provide a technique for enhancing measurement sensitivity or a technique for avoiding a hemoglobin influence in an immunoassay method. The invention is directed to a method for enhancing measurement sensitivity or a hemoglobin influence avoiding method in an immunoassay method, characterized in that the method includes assaying target substance contained in a biological sample through antigen-antibody reaction in the presence of a macrocyclic compound.